Lopamudra Roy

Lopamudra

All articles by Lopamudra Roy

  1. Mast Therapeutics begins enrolment for Phase II INABLE-TRAINING study of AIR001 to treat HFpEF

    US-based biopharmaceutical company Mast Therapeutics has begun enrolment for its Phase II INABLE-TRAINING study of AIR001 to treat heart failure…
    Read More…

    7 Dec
  2. Antibodies treatment can clear infection for SHIV-exposed infant macaques

    The Oregon National Primate Research Centre has revealed that infant rhesus macaques exposed to an HIV-like virus can clear the…
    Read More…

    22 Mar
Close
Close
Close

Go Top